February 22, 2021
Article
Final analysis results from the phase 3 IMpower110 trial show the benefit of atezolizumab over chemotherapy in a non–small cell lung cancer subgroup.
January 31, 2021
Article
Datopotamab deruxtecan showed antitumor activity in the treatment of patients with advanced or metastatic non–small cell lung cancer, according to updated results of the phase 1 TROPION-PanTumor01 trial.
January 22, 2021
Article
Positive response and disease control rates were observed in 2 separate studies when patients with head and neck squamous cell carcinoma and melanoma received the combination of eganelisib and nivolumab.
January 18, 2021
Article
In patients with previously treated advanced hepatocellular carcinoma (HCC), single-agent pembrolizumab (Keytruda) maintained numerical improvement in survival (OS), updated findings randomized phase 3 KEYNOTE-240 trial show.